Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.
about
Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Persistent anxiolytic affects after chronic administration of the CRF₁ receptor antagonist R121919 in rats.Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.Progress in corticotropin-releasing factor-1 antagonist development.Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent ratsThe CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent.Experimental gastritis in mice enhances anxiety in a gender-related manner.Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice.Neurobiology of stress-induced reproductive dysfunction in female macaques.Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring.Effect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice modelsSex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity.
P2860
Q27014879-CA8540DB-AF0F-4E1D-ACDE-3A4817F1600CQ30467178-8F998573-806D-467D-BEB9-5BC0FA1950D9Q30468942-BD18A9D8-A53E-4D4F-87B2-99FA9942DBA8Q30475627-38D46C8D-AE15-48B0-AF2A-DBE6F651C70CQ30486793-4B27BFF3-CE8B-4E7D-890F-A7B49573DC6DQ30487068-BA141283-EBF3-40A2-A892-85F3620FEDFAQ35178236-CC1EB58D-792E-41AE-A0A9-FFC84AEF8D32Q35178241-D6B1CDA4-4F7E-4F4F-89B1-05EA12E0DFB3Q35694664-8D36A1D4-8A89-4577-ADE4-E67D3BA7FDD1Q36978884-B9C50BE2-BE21-46B3-8728-BD8A03417661Q37676884-B936DBC9-86B7-4FF5-9FD5-6E7B7A359D78Q37720094-41648D46-1961-409B-9476-F84A89C2DDC8
P2860
Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@en
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@nl
type
label
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@en
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@nl
prefLabel
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@en
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@nl
P2093
P2860
P356
P1476
Altered serotonergic neurotran ...... r type 1 antagonist NBI 30775.
@en
P2093
Akihiko Oshima
Astrid C E Linthorst
Cornelia Flachskamm
Johannes M H M Reul
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300267
P407
P577
2003-12-01T00:00:00Z
P6179
1036115823